Page last updated: 2024-09-02

alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and methylene blue

alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol has been researched along with methylene blue in 1 studies

Compound Research Comparison

Studies
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)
Trials
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)
Recent Studies (post-2010)
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)
Studies
(methylene blue)
Trials
(methylene blue)
Recent Studies (post-2010) (methylene blue)
901211,0673944,258

Protein Interaction Comparison

ProteinTaxonomyalpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol (IC50)methylene blue (IC50)
Chain E, Fibrin beta chainHomo sapiens (human)9.253
integrase, partialHuman immunodeficiency virus 11.958
lens epithelium-derived growth factor p75Homo sapiens (human)1.958
Apoptotic peptidase activating factor 1Homo sapiens (human)15.5
neutrophil cytosol factor 1Homo sapiens (human)0.39
caspase-9 isoform alpha precursorHomo sapiens (human)17
caspase-3 isoform a preproproteinHomo sapiens (human)17
Glutathione reductasePlasmodium falciparum 3D76.4
Amyloid-beta precursor proteinHomo sapiens (human)0.5
Microtubule-associated protein tauHomo sapiens (human)2.2333
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.5
Amine oxidase [flavin-containing] AHomo sapiens (human)0.07
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.5
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furukawa, S; Hiramatsu, M; Kameyama, T; Karasawa, K; Mamiya, T; Nabeshima, T; Noda, A; Noda, Y; Yamada, K1

Other Studies

1 other study(ies) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and methylene blue

ArticleYear
Effects of sigma receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in mice.
    Neuropharmacology, 2000, Volume: 39, Issue:12

    Topics: Analgesics, Opioid; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Behavior, Animal; Brain Chemistry; Cyclic GMP; Enzyme Inhibitors; Guanidines; Indazoles; Male; Methylene Blue; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pentazocine; Phenazocine; Pyrimidines; Receptors, sigma

2000